Dietary Peanuts and Nutrition-Related Outcomes

NCT07244458 · Recruiting

Last updated 2026-05-28

This clinical trial tests whether eating peanuts affects feelings of fullness in adults who are overweight or obese.

Status Recruiting Currently enrolling participants.

Phase Not applicable Not a phased drug trial (e.g. a device or behavioral study).

Type Interventional (clinical trial)

Design Randomized, open-label (no blinding) supportive care study

Participants 64 people Planned (estimated).

Who can join Ages 18–80 · all sexes Healthy volunteers accepted.

Timeline Started 2026-04 · est. completion 2027-12

Where 1 site · United States

What this study is testing ClinicalTrials.gov NCT07244458 ↗

Description as written by the study sponsor.

This study will look at how eating peanuts every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding peanuts to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating peanuts improves overall diet quality and health markers like tiredness and certain levels in blood.

Treatments tested

Peanuts Dietary supplement

Participants will eat 2 ounces, or about 53 grams, of dry-roasted, lightly salted peanuts each day along with their regular diet
Dual-energy X-ray absorptiometry (DEXA) scans Procedure

DEXA scans will be used to measure body fat

Main thing measured	Change is Satiety as measured by the Hunger and Satiety Visual Analog Scales (VAS)
Sponsor	Ian J. Neeland, MD
Conditions studied	Dietary Change, Obesity & Overweight, Food Acceptance
GLP-1 drugs	—

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07244458 ↗